![]() |
市場調査レポート
商品コード
1722611
水頭症シャント市場レポート:タイプ別、製品タイプ別、年齢層別、エンドユーザー別、地域別、2025年~2033年Hydrocephalus Shunts Market Report by Type, Product Type, Age Group, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
水頭症シャント市場レポート:タイプ別、製品タイプ別、年齢層別、エンドユーザー別、地域別、2025年~2033年 |
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
|
水頭症シャントの世界市場規模は2024年に4億6,720万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに6億4,210万米ドルに達し、2025年から2033年にかけて3.42%の成長率(CAGR)を示すと予測しています。同市場は主に、水頭症の罹患率の上昇、ヘルスケアの高度化、シャント設計の技術革新によって牽引されています。さらに、先天性水頭症患者の増加と小児人口の急速な増加が市場成長を大きく促進しています。
先天性疾患と小児人口の増加
水頭症シャントの世界市場シェアにおける重要な動向は、乳幼児や小児における先天性水頭症の有病率の増加です。さらに、小児人口の急増も市場力学において極めて重要な役割を果たしています。The World Countsによると、毎日38万5,000人、すなわち年間1億4,000万人の赤ちゃんが誕生しています。先天性疾患の増加が、小児用シャント・ソリューションの需要を押し上げています。ジョン・ホプキンス病院によると、米国では1,000人に1人か2人が先天性水頭症だといいます。その結果、メーカーは現在、この年齢層特有の生理学的・解剖学的ニーズを考慮し、小児・乳児専用のシャントの設計に力を入れています。
先端技術の急速な採用
世界の水頭症シャント市場は、サイフォン防止シャントやプログラマブルシャントなどの先端技術の採用が急増している顕著な動向を目の当たりにしています。このような技術革新は、脳脊髄液の流れを正確に調整することで、患者の予後を改善します。Journal of Neurosurgery誌に掲載された調査論文によると、プログラム可能なシャントは水頭症治療において、プログラム不可能なシャントよりも再手術率が低いです。その結果、プログラム可能なシャントの方が費用対効果が高いことが証明されています。調査によると、プログラム可能なシャントを使用した患者の7%に再手術が必要であったのに対し、プログラム不可能なシャントを使用した患者では21.6%に再手術が必要でした。さらに、遠隔モニタリングや遠隔医療システムの導入により、術後のケアが向上し、頻繁な通院の必要性が低下するため、さらに普及が進んでいます。
新興国における製品の普及率の増加
水頭症の世界市場シェアは、主にヘルスケア支出の増加とヘルスケアインフラの強化により、新興国市場で明るい見通しが見えています。中国やインドのような国々では、患者意識の高まりと医療施設の改善により、水頭症シャントの普及率が上昇しています。業界レポートによると、アジア太平洋地域は2024年に堅調な経済成長を示すと予測されており、インドのGDPは5%成長すると推定されています。市場の拡大は、ヘルスケア施設を強化する政府の取り組みや、満たされていない医療需要への対応を目標とするこれらの経済圏における大手企業のプレゼンス強化によってさらに推進されます。
The global hydrocephalus shunts market size reached USD 467.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 642.1 Million by 2033, exhibiting a growth rate (CAGR) of 3.42% during 2025-2033. The market is primarily driven by the rising incidence of hydrocephalus, advanced healthcare infrastructure, and technological innovations in shunts design. Moreover, increasing cases of congenital hydrocephalus and rapid proliferation of pediatric population are significantly driving the market growth.
Increasing Congenital Cases and Pediatric Population
A significant trend in the global hydrocephalus shunts market share is the increasing prevalence of congenital hydrocephalus among infants and children. In addition, rapid growth in pediatric population is also playing a pivotal role in market dynamics. According to The World Counts, each day 385,000 babies are born, i.e., 140 million a year. The heightening incidents of congenital cases has boosted the demand for pediatric shunt solutions. According to John Hopkins Hospital, 1 or 2 of every 1000 infants born in U.S. have congenital hydrocephalus. As a result, manufacturers are currently emphasizing on designing specialized shunts for children and infants, acknowledging the distinct physiological and anatomical needs of this age group.
Rapid Adoption of Advanced Technologies
The global hydrocephalus shunts market is witnessing a notable trend towards the escalating adoption of advanced technologies, including anti-siphon and programmable shunts. Such innovations improve patient outcomes by permitting accurate adjustments of cerebrospinal fluid flow. According to a research article published in the Journal of Neurosurgery, programmable shunts depict lower revision rates than nonprogrammable shunts for the treatment of hydrocephalus. Consequently, programmable shunts are proven to be more cost-efficient. The research showed that 7% of patients with programmable shunts needed revisions, while 21.6% of patients with nonprogrammable shunts required revisions. Additionally, the incorporation of remote monitoring and telehealth systems is further driving adoption by improving post-operative care and lowering the need for frequent hospital visits.
Increasing Product Prevalence in Emerging Economies
The global hydrocephalus market share is witnessing a positive outlook in emerging market principally due to increase in healthcare spending and enhanced healthcare infrastructure. Countries like China and India are undergoing elevated adoption rates of hydrocephalus shunts primarily because of heightening patient awareness and improved medical facilities. As per industry reports, Asia Pacific is projected to depict a robust economic growth in 2024 with India's GDP estimated to grow by 5%. The market expansion is further propelled by government initiatives to enhance healthcare facilities and the strengthening presence of major companies in these economies, targeting to address the unmet medical demands.
Ventriculo-peritoneal accounts for the majority of the market share
The ventriculo-peritoneal (VP) represents the majority of the global hydrocephalus shunts market share as it is reliable, highly effective, and is largely accepted in clinical applications. VP shunts demonstrate high success rates in patients with hydrocephalus, aiding in strengthening its dominance in the market dynamics. The widespread utilization of VP shunts in adults as well as pediatrics further facilitate their market growth. As per a clinical report, approximately 750,000 individuals are diagnosed with hydrocephalus, while 160,000 VP shunts are implanted each year globally. Moreover, the robust support from medical professionals and advantageous healthcare policies assists in sustaining hydrocephalus shunts market share and growth.
Hydrocephalus valves hold the largest share of the industry
Hydrocephalus valves play a critical role in regulating the flow of cerebrospinal fluid. Valves are integral component of hydrocephalus shunt system as they aid in maintaining intracranial pressure. Adjustable pressure valves have flexible built, designed to address pressure settings as per the patient needs. Fixed pressure valves are comparatively less versatile but are cost-efficient and reliable. Advancements in manufacturing technology of valves and innovations further strengthen the segment's growth in the global hydrocephalus shunts market share. For instance, Integra LifeSciences has innovated the valves design by manufacturing various variants of fixed pressure valves, including Ultra VS valves, Pudenz Valves, Mishler On/Off valves, and CODMAN HAKIM Precision Fixed Pressure Valves.
Children represent the leading market segment
Children hold the largest segment in the global hydrocephalus shunts market share due to an elevated prevalence of congenital hydrocephalus and the intense demand for early detection and treatment. According to the National Institutes of Health, it is estimated that each year approximately 400,000 new cases of pediatric hydrocephalus will develop globally. Furthermore, according to a research article published in the Journal of Neurosurgey, Asia also depicts prevalence of pediatric hydrocephalus. In the study, 29% of nonpostinfectious hydrocephalus and 10.7% of postinfectious hydrocephalus were identified across Asia. Specialized shunt systems and development in pediatric neurosurgery for children plays a pivotal role in hydrocephalus shunts market dynamics. Additionally, intensifying awareness about neurogenerative diseases in children and enhanced diagnostics techniques facilitates the segment dominance.
Hospitals exhibit a clear dominance in the market
Hospitals hold the largest segment as an end user in the global hydrocephalus shunts market forecast because of their superior medical infrastructure, ability to execute critical surgeries, and competent healthcare professionals. Hospitals greatly profit from elevated patient inflow, particularly for critical hydrocephalus cases that demand specialized treatments. According to Hydrocephalus Association, pediatric hydrocephalus accounts for over 40,000 hospital admissions annually, with nearly 10,000 of these admissions resulting from shunt malfunctions. Moreover, facilities like thorough post-surgical care and advanced technologies also fortifies their position in the hydrocephalus shunt market dynamics. Additionally, strategic partnerships between manufacturers and hospitals facilitates a reliable supply chain, improving latter's pivotal role in this market share.
North America leads the market, accounting for the largest hydrocephalus shunts market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hydrocephalus shunts.
North America is the dominant region in the global hydrocephalus shunts market share primarily due to increasing prevalence of hydrocephalus and cutting-edge healthcare infrastructure. According to USF Health, more than 800,000 Americans are suffering with hydrocephalus, while 1%-5% patients that are suffering with dementia are estimated to have hydrocephalus. The region, particularly United States, is leading in research and development sector and extensive utilization of advanced medical technologies. For instance, Indiana University (IU) in Indianapolis was granted with USD 243 million research fund from the National Institutes of Health in 2023. IU is growing rapidly in R&D and has established Hydrocephalus Research Center that aims to discover hydrocephalus solutions. Canada also has a substantial contribution in the regional market dynamics due to rising patient awareness and robust healthcare policies in the country. This regional domination is also strengthened by preferable pay back policies and an entrenched healthcare providers network.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)